Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis

Red blood cells (RBCs) have been found to synthesize and release both nitric oxide (NO) and cyclic guanosine monophosphate (cGMP), contributing to systemic NO bioavailability. These RBC functions resulted impaired in chronic kidney disease (CKD). This study aimed to evaluate whether predialysis (con...

Full description

Bibliographic Details
Main Authors: Carola Palmerini, Luca Piscitani, Giuseppina Bologna, Chiara Riganti, Paola Lanuti, Domitilla Mandatori, Lorenzo Di Liberato, Giorgia Di Fulvio, Vittorio Sirolli, Giulia Renda, Caterina Pipino, Marco Marchisio, Mario Bonomini, Assunta Pandolfi, Natalia Di Pietro
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/6/3049
id doaj-11ee54441e4c4e46a9938b42ce4c73b6
record_format Article
spelling doaj-11ee54441e4c4e46a9938b42ce4c73b62021-03-18T00:00:24ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-03-01223049304910.3390/ijms22063049Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal DialysisCarola Palmerini0Luca Piscitani1Giuseppina Bologna2Chiara Riganti3Paola Lanuti4Domitilla Mandatori5Lorenzo Di Liberato6Giorgia Di Fulvio7Vittorio Sirolli8Giulia Renda9Caterina Pipino10Marco Marchisio11Mario Bonomini12Assunta Pandolfi13Natalia Di Pietro14Department of Medical, Oral and Biotechnological Sciences, G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyNephrology and Dialysis Unit, SS. Annunziata Hospital, 66100 Chieti, ItalyCenter for Advanced Studies and Technology-CAST (ex CeSI-MeT), G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyDepartment of Oncology, University of Torino, 10124 Torino, ItalyCenter for Advanced Studies and Technology-CAST (ex CeSI-MeT), G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyDepartment of Medical, Oral and Biotechnological Sciences, G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyNephrology and Dialysis Unit, SS. Annunziata Hospital, 66100 Chieti, ItalyNephrology and Dialysis Unit, SS. Annunziata Hospital, 66100 Chieti, ItalyNephrology and Dialysis Unit, SS. Annunziata Hospital, 66100 Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyDepartment of Medical, Oral and Biotechnological Sciences, G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyCenter for Advanced Studies and Technology-CAST (ex CeSI-MeT), G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyNephrology and Dialysis Unit, SS. Annunziata Hospital, 66100 Chieti, ItalyDepartment of Medical, Oral and Biotechnological Sciences, G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyDepartment of Medical, Oral and Biotechnological Sciences, G. d’Annunzio University Chieti-Pescara, 66100 Chieti, ItalyRed blood cells (RBCs) have been found to synthesize and release both nitric oxide (NO) and cyclic guanosine monophosphate (cGMP), contributing to systemic NO bioavailability. These RBC functions resulted impaired in chronic kidney disease (CKD). This study aimed to evaluate whether predialysis (conservative therapy, CT) and dialysis (peritoneal dialysis, PD; hemodialysis, HD) therapies used during CKD progression may differently affect NO-synthetic pathway in RBCs. Our data demonstrated that compared to PD, although endothelial-NO-synthase activation was similarly increased, HD and CT were associated to cGMP RBCs accumulation, caused by reduced activity of cGMP membrane transporter (MRP4). In parallel, plasma cGMP levels were increased by both CT and HD and they significantly decreased after hemodialysis, suggesting that this might be caused by reduced cGMP renal clearance. As conceivable, compared to healthy subjects, plasma nitrite levels were significantly reduced by HD and CT but not in patients on PD. Additionally, the increased carotid intima-media thickness (IMT) values did not reach the significance exclusively in patients on PD. Therefore, our results show that PD might better preserve the synthetic NO-pathway in CKD-erythrocytes. Whether this translates into a reduced development of uremic vascular complications requires further investigation.https://www.mdpi.com/1422-0067/22/6/3049erythrocyteschronic kidney diseasenitric oxidecGMPcardiovascular diseaseMRP4
collection DOAJ
language English
format Article
sources DOAJ
author Carola Palmerini
Luca Piscitani
Giuseppina Bologna
Chiara Riganti
Paola Lanuti
Domitilla Mandatori
Lorenzo Di Liberato
Giorgia Di Fulvio
Vittorio Sirolli
Giulia Renda
Caterina Pipino
Marco Marchisio
Mario Bonomini
Assunta Pandolfi
Natalia Di Pietro
spellingShingle Carola Palmerini
Luca Piscitani
Giuseppina Bologna
Chiara Riganti
Paola Lanuti
Domitilla Mandatori
Lorenzo Di Liberato
Giorgia Di Fulvio
Vittorio Sirolli
Giulia Renda
Caterina Pipino
Marco Marchisio
Mario Bonomini
Assunta Pandolfi
Natalia Di Pietro
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis
International Journal of Molecular Sciences
erythrocytes
chronic kidney disease
nitric oxide
cGMP
cardiovascular disease
MRP4
author_facet Carola Palmerini
Luca Piscitani
Giuseppina Bologna
Chiara Riganti
Paola Lanuti
Domitilla Mandatori
Lorenzo Di Liberato
Giorgia Di Fulvio
Vittorio Sirolli
Giulia Renda
Caterina Pipino
Marco Marchisio
Mario Bonomini
Assunta Pandolfi
Natalia Di Pietro
author_sort Carola Palmerini
title Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis
title_short Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis
title_full Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis
title_fullStr Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis
title_full_unstemmed Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis
title_sort predialysis and dialysis therapies differently affect nitric oxide synthetic pathway in red blood cells from uremic patients: focus on peritoneal dialysis
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-03-01
description Red blood cells (RBCs) have been found to synthesize and release both nitric oxide (NO) and cyclic guanosine monophosphate (cGMP), contributing to systemic NO bioavailability. These RBC functions resulted impaired in chronic kidney disease (CKD). This study aimed to evaluate whether predialysis (conservative therapy, CT) and dialysis (peritoneal dialysis, PD; hemodialysis, HD) therapies used during CKD progression may differently affect NO-synthetic pathway in RBCs. Our data demonstrated that compared to PD, although endothelial-NO-synthase activation was similarly increased, HD and CT were associated to cGMP RBCs accumulation, caused by reduced activity of cGMP membrane transporter (MRP4). In parallel, plasma cGMP levels were increased by both CT and HD and they significantly decreased after hemodialysis, suggesting that this might be caused by reduced cGMP renal clearance. As conceivable, compared to healthy subjects, plasma nitrite levels were significantly reduced by HD and CT but not in patients on PD. Additionally, the increased carotid intima-media thickness (IMT) values did not reach the significance exclusively in patients on PD. Therefore, our results show that PD might better preserve the synthetic NO-pathway in CKD-erythrocytes. Whether this translates into a reduced development of uremic vascular complications requires further investigation.
topic erythrocytes
chronic kidney disease
nitric oxide
cGMP
cardiovascular disease
MRP4
url https://www.mdpi.com/1422-0067/22/6/3049
work_keys_str_mv AT carolapalmerini predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
AT lucapiscitani predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
AT giuseppinabologna predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
AT chiarariganti predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
AT paolalanuti predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
AT domitillamandatori predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
AT lorenzodiliberato predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
AT giorgiadifulvio predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
AT vittoriosirolli predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
AT giuliarenda predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
AT caterinapipino predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
AT marcomarchisio predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
AT mariobonomini predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
AT assuntapandolfi predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
AT nataliadipietro predialysisanddialysistherapiesdifferentlyaffectnitricoxidesyntheticpathwayinredbloodcellsfromuremicpatientsfocusonperitonealdialysis
_version_ 1724218032271654912